Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire

China and the U.S. rank No. 1 and No. 2 in the number of cancer patients and overall cancer burden.

Read the full post on Forbes - Healthcare

Russell Flannery, Forbes Staff